{"url_path":"/sec/cik-0002093375/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/2093375/0002093375-26-000014-index.html","accession_number":"0002093375-26-000014","cik":"0002093375","ticker":null,"issuer_name":"DentonX Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/2093375/0002093375-26-000014-index.html","primary_entity_key":"0002093375","primary_entity_name":"DentonX Inc"},"word_count":101,"has_tables":true,"body_markdown":"**Item 5. Other Information.**\n\n \n\nDuring the three months ended March 31, 2026, none of our directors or officers (as defined in Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any “non-Rule 10b5-1 trading arrangement” (as defined by Item 408(c) of Regulation S-K). However, certain of our directors and officers may adopt 10b5-1 plans or non-Rule 10b5-1 trading arrangements in the future."}